Company & Sponsor Intelligence
Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting1
Completed0
Countries0
Therapeutic footprint
autism
Indexed studies
NCT07177677A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder
autism · PHASE1
autism · PHASE1
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →